Trials / Completed
CompletedNCT02097862
Adipose Cells for Degenerative Disc Disease
An Open Label, Non-Randomized, Multi-Center Study To Assess The Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intra-Discally in Patients With Degenerative Disc Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Bioheart, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with diagnosed degenerative disc disease.
Detailed description
This will be an open-label, non-randomized, multi-center study of ASC implantation performed intra-discally. ASCs will be derived from the patient's adipose-derived tissue. Liposuction using local anesthesia and syringe collection will be performed to collect the adipose tissue specimen for subsequent processing to isolate the stem cells. The adipose tissue specimen will be collected from the patient's abdomen using a liposuction cannula. In addition, a sample of peripheral blood will be collected for isolation of platelet rich plasma. The adipose tissue is processed for separation of the adipose tissue-derived stem cells, which are then resuspended in platelet rich plasma and transferred for intra-discal administration. The number of cells injected will vary depending on the amount of tissue processed and the number of cells obtained from the process. Following the injections follow-up data will be collected 3, 6 and 12 months after treatment. Total study time frame is anticipated to be approximately 6 months. This study will enroll approximately 100 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Adipose Stem Cells | Injection of adipose derived stem cells intra-discally |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2014-03-27
- Last updated
- 2017-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02097862. Inclusion in this directory is not an endorsement.